Robert A. Schnoll

6.1k total citations
182 papers, 4.4k citations indexed

About

Robert A. Schnoll is a scholar working on Physiology, Applied Psychology and Molecular Biology. According to data from OpenAlex, Robert A. Schnoll has authored 182 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Physiology, 45 papers in Applied Psychology and 44 papers in Molecular Biology. Recurrent topics in Robert A. Schnoll's work include Smoking Behavior and Cessation (127 papers), Nicotinic Acetylcholine Receptors Study (42 papers) and Behavioral Health and Interventions (41 papers). Robert A. Schnoll is often cited by papers focused on Smoking Behavior and Cessation (127 papers), Nicotinic Acetylcholine Receptors Study (42 papers) and Behavioral Health and Interventions (41 papers). Robert A. Schnoll collaborates with scholars based in United States, Canada and United Kingdom. Robert A. Schnoll's co-authors include Caryn Lerman, E. Paul Wileyto, Rachel F. Tyndale, Frank T. Leone, Lisa L. Harlow, Neal L. Benowitz, Paul M. Cinciripini, Larry W. Hawk, Tony P. George and Freda Patterson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Robert A. Schnoll

178 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Schnoll United States	38	2.6k	1.0k	840	770	695	182	4.4k
Benjamin A. Toll United States	37	2.5k 1.0×	445 0.4×	705 0.8×	1.1k 1.4×	760 1.1×	157	4.4k
Lisa Sanderson Cox United States	30	2.4k 0.9×	840 0.8×	473 0.6×	824 1.1×	605 0.9×	102	3.7k
Kolawole S. Okuyemi United States	42	2.7k 1.0×	511 0.5×	342 0.4×	793 1.0×	991 1.4×	154	4.5k
Ivana T. Croghan United States	48	3.9k 1.5×	1.5k 1.5×	425 0.5×	1.0k 1.4×	1.4k 2.1×	225	7.0k
Paul M. Cinciripini United States	49	4.3k 1.6×	1.4k 1.3×	805 1.0×	1.6k 2.1×	1.3k 1.9×	266	8.4k
Robyn Richmond Australia	42	3.3k 1.3×	517 0.5×	381 0.5×	1.1k 1.4×	1.2k 1.8×	186	6.4k
Tim McAfee United States	32	3.3k 1.2×	446 0.4×	197 0.2×	934 1.2×	1.3k 1.9×	65	4.7k
Nicole L. Nollen United States	34	1.5k 0.6×	350 0.3×	276 0.3×	553 0.7×	1.2k 1.8×	121	3.5k
Peter Selby Canada	38	1.9k 0.7×	528 0.5×	427 0.5×	821 1.1×	2.5k 3.6×	282	6.7k
Cheryl Oncken United States	39	2.7k 1.0×	984 1.0×	143 0.2×	569 0.7×	854 1.2×	110	4.6k

Countries citing papers authored by Robert A. Schnoll

Since Specialization

Citations

This map shows the geographic impact of Robert A. Schnoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Schnoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Schnoll more than expected).

Fields of papers citing papers by Robert A. Schnoll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Schnoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Schnoll. The network helps show where Robert A. Schnoll may publish in the future.

Co-authorship network of co-authors of Robert A. Schnoll

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Schnoll. A scholar is included among the top collaborators of Robert A. Schnoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Schnoll. Robert A. Schnoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schnoll, Robert A., et al.. (2025). Differences in Cognition and Smoking Abstinence Rates Among People With and Without HIV Who Smoke. Nicotine & Tobacco Research. 27(10). 1831–1839. 1 indexed citations

Schnoll, Robert A., Daniel Blumenthal, E. Paul Wileyto, et al.. (2025). Pilot Trial of a Behavioral Economics-Informed Clinical Decision Support Alert to Improve Inpatient Tobacco Use Treatment Rates. Nicotine & Tobacco Research. 27(12). 2265–2272. 1 indexed citations

Wileyto, E. Paul, Samuel U Takvorian, Peter Gabriel, et al.. (2024). Predictive Value of Individual Behavioral Risk Factors for New Mood‐Related Psychiatric Disorder After Diagnosis of Cancer. Psycho-Oncology. 33(12). e70046–e70046. 1 indexed citations

Schnoll, Robert A., Frank T. Leone, Paul Wileyto, et al.. (2023). A randomized clinical trial testing two implementation strategies to promote the treatment of tobacco dependence in community mental healthcare. Drug and Alcohol Dependence. 247. 109873–109873. 3 indexed citations

Bilker, Warren B., Xiaoyan Han, Jessica S. Merlin, et al.. (2023). Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz‐Based Therapy in People With HIV Who Smoke. Clinical Pharmacology & Therapeutics. 115(1). 80–85. 1 indexed citations

Bilker, Warren B., Michael Plankey, Deanna Ware, et al.. (2022). Brief Report: HIV Infection Does Not Explain Higher Nicotine Metabolism in People Living With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(5). 497–501. 3 indexed citations

Colder, Craig R., Martin C. Mahoney, Gary E. Swan, et al.. (2022). Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving. Nicotine & Tobacco Research. 24(11). 1803–1810. 5 indexed citations

Oh, April, Karen M. Emmons, Ross C. Brownson, et al.. (2022). Speeding implementation in cancer: The National Cancer Institute’s Implementation Science Centers in Cancer Control. JNCI Journal of the National Cancer Institute. 115(2). 131–138. 18 indexed citations

Molebatsi, Keneilwe, et al.. (2022). Implementation Planning for Integrating Depression Screening in Diabetes Mellitus and HIV Clinics in Botswana. PubMed. 2(4). 384–393. 2 indexed citations

10.

Schnoll, Robert A., E. Paul Wileyto, Frank T. Leone, et al.. (2021). Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder. American Journal on Addictions. 30(4). 382–388. 1 indexed citations

11.

Schnoll, Robert A., Steven L. Bernstein, Annette R. Kaufman, et al.. (2021). COVID-19 Challenges Confronted by Smoking Cessation Clinical Trials for People Living With HIV: The Experience of Grantees of the US National Cancer Institute. Nicotine & Tobacco Research. 23(9). 1629–1632. 5 indexed citations

12.

Siegel, Scott D., et al.. (2020). The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. Cancer Prevention Research. 13(3). 261–272. 29 indexed citations

13.

Schnoll, Robert A., Katrina J. Serrano, Frank T. Leone, et al.. (2020). The effect of varenicline on mood and cognition in smokers with HIV. Psychopharmacology. 237(4). 1223–1231. 9 indexed citations

14.

Wileyto, E. Paul, Robert A. Schnoll, David Metzger, et al.. (2020). No differences in delay discounting between smokers with and without HIV. Psychopharmacology. 238(2). 529–537. 2 indexed citations

15.

Ashare, Rebecca L., E. Paul Wileyto, Robert Gross, et al.. (2020). Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV.. Psychology of Addictive Behaviors. 35(7). 788–796. 6 indexed citations

16.

Siegel, Scott D., Jean‐Philippe Laurenceau, Douglas Ziedonis, et al.. (2020). Assessing barriers to providing tobacco use disorder treatment in community mental health settings with a revised version of the Smoking Knowledge, Attitudes, and Practices (S-KAP) instrument. Addictive Behaviors. 114. 106735–106735. 10 indexed citations

17.

Ashare, Rebecca L., et al.. (2019). Improved clinical outcomes among persons with HIV who quit smoking. AIDS Care. 32(10). 1217–1223. 7 indexed citations

18.

Jao, Nancy C., et al.. (2018). Menthol Cigarettes, Tobacco Dependence, and Smoking Persistence: The Need to Examine Enhanced Cognitive Functioning as a Neuropsychological Mechanism. Nicotine & Tobacco Research. 22(4). 466–472. 6 indexed citations

19.

Jao, Nancy C., Ravi Kalhan, Frank T. Leone, et al.. (2018). Cancer Patients Enrolled in a Smoking Cessation Clinical Trial: Characteristics and Correlates of Smoking Rate and Nicotine Dependence. PubMed. 2018. 1–7. 13 indexed citations

20.

Land, Stephanie R., Benjamin A. Toll, Carol M. Moinpour, et al.. (2016). Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research. Clinical Cancer Research. 22(8). 1907–1913. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact